PhoenixBio Management
Management criteria checks 2/4
PhoenixBio's CEO is Takashi Shimada, appointed in Jan 2018, has a tenure of 7.33 years. directly owns 1.51% of the company’s shares, worth ¥20.01M. The average tenure of the management team and the board of directors is 10.9 years and 5.9 years respectively.
Key information
Takashi Shimada
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.3yrs |
| CEO ownership | 1.5% |
| Management average tenure | 10.9yrs |
| Board average tenure | 5.9yrs |
Recent management updates
Recent updates
PhoenixBio Co., Ltd. (TSE:6190) Looks Inexpensive After Falling 33% But Perhaps Not Attractive Enough
Apr 07
PhoenixBio Co., Ltd.'s (TSE:6190) Shares Bounce 31% But Its Business Still Trails The Industry
Feb 19PhoenixBio Co., Ltd.'s (TSE:6190) Share Price Is Matching Sentiment Around Its Revenues
Nov 18CEO
Takashi Shimada (65 yo)
7.3yrs
Tenure
Takashi Shimada serves as the President and CEO at PhoenixBio Co. Ltd. since June 2018 and has been its Representative Director. He served as Executive Vice President and Vice Chairman of the Board at Phoe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 19.5yrs | no data | 1.23% ¥ 16.4m | |
| President | 7.3yrs | no data | 1.51% ¥ 20.0m | |
| Senior MD | 10.9yrs | no data | 0.75% ¥ 9.9m | |
| Executive Director of Research & Development and Director | 10.9yrs | no data | 0.63% ¥ 8.3m |
10.9yrs
Average Tenure
66yo
Average Age
Experienced Management: 6190's management team is seasoned and experienced (10.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 19.5yrs | no data | 1.23% ¥ 16.4m | |
| President | no data | no data | 1.51% ¥ 20.0m | |
| Senior MD | no data | no data | 0.75% ¥ 9.9m | |
| Executive Director of Research & Development and Director | no data | no data | 0.63% ¥ 8.3m | |
| Auditor | 5.9yrs | no data | 0.012% ¥ 163.9k | |
| Independent Outside Director | 8.9yrs | no data | no data | |
| Auditor | 5.9yrs | no data | no data | |
| External Auditor | 2.9yrs | no data | no data |
5.9yrs
Average Tenure
64yo
Average Age
Experienced Board: 6190's board of directors are considered experienced (5.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/06 19:24 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PhoenixBio Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.